(MO) Altria - Ratings and Ratios
Cigarettes, Cigars, Smokeless Tobacco, Nicotine Pouches, Vapor Products
MO EPS (Earnings per Share)
MO Revenue
Description: MO Altria
Altria Group, Inc. is a leading manufacturer and seller of tobacco products in the United States, with a diverse portfolio of brands including Marlboro, Black & Mild, Copenhagen, and NJOY. The companys products cater to various consumer preferences, from traditional cigarettes to oral tobacco products and e-vapor solutions.
From a business perspective, Altria Group has a strong distribution network, selling its products to both distributors and large retail organizations. This diversified sales strategy enables the company to maintain a significant market presence. Key Performance Indicators (KPIs) such as revenue growth, market share, and product mix will be crucial in evaluating the companys future prospects.
Notably, the tobacco industry is subject to various regulatory challenges and shifting consumer preferences, which can impact Altria Groups sales and profitability. The companys ability to adapt to these changes, invest in innovative products, and maintain its brand portfolio will be essential in driving long-term growth. KPIs such as R&D expenditure, brand diversification, and regulatory compliance will be important metrics to monitor.
From a financial perspective, Altria Groups market capitalization and dividend yield are key metrics that investors consider. The companys dividend payout ratio, debt-to-equity ratio, and return on equity (despite the negative RoE reported) are also important indicators of its financial health and ability to generate returns for shareholders.
Overall, Altria Groups performance will be influenced by its ability to navigate the complex tobacco landscape, invest in growth opportunities, and maintain its financial discipline. As a Trading Analyst, it is essential to closely monitor the companys KPIs, industry trends, and regulatory developments to make informed investment decisions.
MO Stock Overview
| Market Cap in USD | 113,695m |
| Sub-Industry | Tobacco |
| IPO / Inception | 1970-01-02 |
MO Stock Ratings
| Growth Rating | 87.0% |
| Fundamental | 78.2% |
| Dividend Rating | 84.7% |
| Return 12m vs S&P 500 | 14.2% |
| Analyst Rating | 3.27 of 5 |
MO Dividends
| Dividend Yield 12m | 6.75% |
| Yield on Cost 5y | 13.85% |
| Annual Growth 5y | 3.30% |
| Payout Consistency | 98.1% |
| Payout Ratio | 76.4% |
MO Growth Ratios
| Growth Correlation 3m | 73.5% |
| Growth Correlation 12m | 92.2% |
| Growth Correlation 5y | 83.8% |
| CAGR 5y | 17.76% |
| CAGR/Max DD 5y | 0.69 |
| Sharpe Ratio 12m | 0.92 |
| Alpha | 29.68 |
| Beta | 0.079 |
| Volatility | 18.04% |
| Current Volume | 5575k |
| Average Volume 20d | 7371.7k |
| Stop Loss | 64.4 (-3%) |
| Signal | 0.92 |
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income (8.79b TTM) > 0 and > 6% of Revenue (6% = 1.22b TTM) |
| FCFTA 0.33 (>2.0%) and ΔFCFTA 7.53pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -20.51% (prev -20.90%; Δ 0.39pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.34 (>3.0%) and CFO 10.88b > Net Income 8.79b (YES >=105%, WARN >=100%) |
| Net Debt (23.43b) to EBITDA (12.00b) ratio: 1.95 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.39 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (1.68b) change vs 12m ago -1.98% (target <= -2.0% for YES) |
| Gross Margin 71.63% (prev 69.53%; Δ 2.09pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 60.73% (prev 59.02%; Δ 1.71pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 11.10 (EBITDA TTM 12.00b / Interest Expense TTM 1.06b) >= 6 (WARN >= 3) |
Altman Z'' 6.10
| (A) -0.13 = (Total Current Assets 2.63b - Total Current Liabilities 6.79b) / Total Assets 32.33b |
| (B) 1.10 = Retained Earnings (Balance) 35.52b / Total Assets 32.33b |
| warn (B) unusual magnitude: 1.10 — check mapping/units |
| (C) 0.35 = EBIT TTM 11.75b / Avg Total Assets 33.36b |
| (D) 0.95 = Book Value of Equity 33.63b / Total Liabilities 35.54b |
| Total Rating: 6.10 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 78.22
| 1. Piotroski 7.0pt = 2.0 |
| 2. FCF Yield 7.83% = 3.91 |
| 3. FCF Margin 52.97% = 7.50 |
| 4. Debt/Equity data missing |
| 5. Debt/Ebitda 2.06 = -0.12 |
| 6. ROIC - WACC 38.51% = 12.50 |
| 7. RoE data missing |
| 8. Rev. Trend -20.56% = -1.03 |
| 9. Rev. CAGR -0.83% = -0.14 |
| 10. EPS Trend 43.62% = 1.09 |
| 11. EPS CAGR 141.8% = 2.50 |
What is the price of MO shares?
Over the past week, the price has changed by -1.86%, over one month by +13.11%, over three months by +13.61% and over the past year by +34.36%.
Is Altria a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of MO is around 76.32 USD . This means that MO is currently undervalued and has a potential upside of +14.91% (Margin of Safety).
Is MO a buy, sell or hold?
- Strong Buy: 3
- Buy: 1
- Hold: 9
- Sell: 1
- Strong Sell: 1
What are the forecasts/targets for the MO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 62.9 | -5.3% |
| Analysts Target Price | 58.4 | -12.1% |
| ValueRay Target Price | 82.7 | 24.5% |
Last update: 2025-08-23 05:03
MO Fundamental Data Overview
CCE Cash And Equivalents = 1.29b USD (last quarter)
P/E Trailing = 13.0909
P/E Forward = 12.4378
P/S = 5.6121
P/B = 27.3016
P/EG = 4.0147
Beta = 0.623
Revenue TTM = 20.26b USD
EBIT TTM = 11.75b USD
EBITDA TTM = 12.00b USD
Long Term Debt = 23.65b USD (from longTermDebt, last quarter)
Short Term Debt = 1.07b USD (from shortTermDebt, last quarter)
Debt = 24.72b USD (Calculated: Short Term 1.07b + Long Term 23.65b)
Net Debt = 23.43b USD (from netDebt column, last quarter)
Enterprise Value = 137.13b USD (113.69b + Debt 24.72b - CCE 1.29b)
Interest Coverage Ratio = 11.10 (Ebit TTM 11.75b / Interest Expense TTM 1.06b)
FCF Yield = 7.83% (FCF TTM 10.73b / Enterprise Value 137.13b)
FCF Margin = 52.97% (FCF TTM 10.73b / Revenue TTM 20.26b)
Net Margin = 43.37% (Net Income TTM 8.79b / Revenue TTM 20.26b)
Gross Margin = 71.63% ((Revenue TTM 20.26b - Cost of Revenue TTM 5.75b) / Revenue TTM)
Tobins Q-Ratio = 4.08 (Enterprise Value 137.13b / Book Value Of Equity 33.63b)
Interest Expense / Debt = 1.11% (Interest Expense 275.0m / Debt 24.72b)
Taxrate = 17.53% (from yearly Income Tax Expense: 2.39b / 13.66b)
NOPAT = 9.69b (EBIT 11.75b * (1 - 17.53%))
Current Ratio = 0.39 (Total Current Assets 2.63b / Total Current Liabilities 6.79b)
Debt / EBITDA = 2.06 (Net Debt 23.43b / EBITDA 12.00b)
Debt / FCF = 2.30 (Debt 24.72b / FCF TTM 10.73b)
Total Stockholder Equity = -3.12b (last 4 quarters mean)
RoA = 27.18% (Net Income 8.79b, Total Assets 32.33b )
RoE = unknown (Net Income TTM 8.79b / Total Stockholder Equity -3.12b)
RoCE = 57.22% (Ebit 11.75b / (Equity -3.12b + L.T.Debt 23.65b))
RoIC = 43.85% (NOPAT 9.69b / Invested Capital 22.10b)
WACC = 5.35% (E(113.69b)/V(138.41b) * Re(6.31%)) + (D(24.72b)/V(138.41b) * Rd(1.11%) * (1-Tc(0.18)))
Shares Correlation 5-Years: -100.0 | Cagr: -2.08%
Discount Rate = 6.31% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 78.54% ; FCFE base≈9.97b ; Y1≈10.14b ; Y5≈11.14b
Fair Price DCF = 117.0 (DCF Value 196.51b / Shares Outstanding 1.68b; 5y FCF grow 1.52% → 3.0% )
Revenue Correlation: -20.56 | Revenue CAGR: -0.83%
Rev Growth-of-Growth: 0.75
EPS Correlation: 43.62 | EPS CAGR: 141.8%
EPS Growth-of-Growth: -76.88
Additional Sources for MO Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle